Michael John Rance
Direttore/Membro del Consiglio presso MNLpharma Ltd.
Profilo
Michael John Rance is a Non-Executive Director at MNLpharma Ltd.
since 2005.
He previously held positions as a Non-Executive Director at Medical Marketing International Group Plc, Vice President-Corporate Affairs at AstraZeneca PLC, and Principal at Reckitt & Colman Plc and AstraZeneca, Inc.
Posizioni attive di Michael John Rance
| Società | Posizione | Inizio |
|---|---|---|
MNLpharma Ltd.
 MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Direttore/Membro del Consiglio | 21/02/2005 |
Precedenti posizioni note di Michael John Rance
| Società | Posizione | Fine |
|---|---|---|
Medical Marketing International Group Plc
 Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 19/09/2007 |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Corporate Officer/Principal | - |
| Reckitt & Colman Plc | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Medical Marketing International Group Plc
Medical Marketing International Group Plc Medical/Nursing ServicesHealth Services Medical Marketing International Group Plc is a life sciences company that identifies and acquires from academic organisations, technologies that have potential to satisfy unmet needs in major markets, such as cancer and infectious disease. It also offers a range of technical support services to United Kingdom academic and commercial bodies. The Group's operation focuses on the areas of vaccines, chemotherapy and Ribozyme anti-virals. Vaccines relates to diseases such as lymphoma, prostate cancer, CEA cancer, myeloma, CMV, influenza and tubercolosis. Chemotherapy research relates to ruthenium and pineapple protease. The company was founded in 1988 and is headquartered in Cambridge, the United Kingdom. | Health Services |
| Reckitt & Colman Plc | Commercial Services |
MNLpharma Ltd.
MNLpharma Ltd. Pharmaceuticals: MajorHealth Technology MNLpharma Ltd. develops and sells pharmaceuticals. It offers therapeutic products, research equipment, and related services. The company developed a molecule Immunomodulators for the treatment of cancer, infectious diseases, and immune disorders. It was founded in 1999 and is headquartered in Aberystwyth, UK | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Health Technology |
- Borsa valori
- Insiders
- Michael John Rance
